作为NSAIDs的高效混合吸收剂,Silane改性化石墨烯量子点作为NSAIDs的高效混合吸收剂
1Department of Chemistry, Faculty of Science, Kuwait University Safat 13060 State of Kuwait Kuwait abdullah.alhendal@ku.edu.kw.
RSC advances
|March 28, 2025
概括
一种使用功能化石墨烯量子点 (f-GQDs) 的新型混合吸附剂被开发用于有效地从水中提取非类固醇抗炎药物 (NSAIDs). 这种可持续的方法为环境和制药分析提供了高回收率和精度.
科学领域:
- 材料科学 材料科学 材料科学
- 分析化学 分析化学
- 纳米技术 纳米技术
背景情况:
- 石墨烯量子点 (GQD) 具有独特的吸附性能.
- 纳米材料的功能化增强了它们的应用潜力.
- 固相提取 (SPE) 对于分析微量污染物至关重要.
研究的目的:
- 开发一种混合吸收材料,用于增强非类固醇抗炎药物 (NSAIDs) 的提取.
- 为了改善吸附性,使用西兰酸盐功能化化石墨烯量子点 (N-GQDs).
- 评估功能化GQDs (f-GQDs) 作为固相提取吸附剂的效率和适用性.
主要方法:
- 通过使用GPTMS和APTS修改N-GQD来合成功能化的GQD (f-GQD).
- 使用TEM,SEM,XPS,FT-IR,TGA,AFM和泽塔潜力分析进行f-GQD的表征.
- 从水样中提取NSAIDs的固体相提取分析参数的优化.
主要成果:
- f-GQDs复合物表现出增强的疏水性和增加的吸附点.
- 该SPE方法表现出极好的线性 (r 2> ≥0.99) 和低检测极限 (15.7223.60 μg L -1).
- 在NSAID测定中实现了高恢复率 (9598.7%) 和可重复性 (RSD<10%).
结论:
- 开发的f-GQDs材料是NSAIDs的SPE的高效和可持续吸收剂.
- 西兰对N-GQD的协同作用显著改善了提取能力.
- 这种方法在环境监测和制药分析方面具有很大的潜力,因为它具有很高的性能和最小的吸附剂要求.
更多相关视频
08:53Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
8.3K
08:00Author Spotlight: Standardizing the Development of Amine-Based Silica Composites as CO2 Adsorbents for Direct Air Capture
Published on: September 29, 2023
3.4K
相关概念视频
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...